TAYLOR LINCOLN: Open Payments
NPI 1043705080 · HARRISONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 95 payments from 23 companies in 2025. Trend: 2023 $1,497 · 2024 $1,163 · 2025 $1,539
Food & beverage: $1,539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $302 |
| Novo Nordisk Inc | 7 | $146 |
| Amgen Inc. | 15 | $144 |
| Vanda Pharmaceuticals Inc. | 8 | $144 |
| PFIZER INC. | 15 | $144 |
| SHIELD THERAPEUTICS INC | 2 | $94 |
| Dexcom, Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
Products named: VRAYLAR, FANAPT, Ozempic, ACCRUFER, OTEZLA, NURTEC ODT, Dexcom G6 Transmitter, QULIPTA.
Industry payments across MO — which companies pay providers there.
